Psychiatry News and Research

RSS

Psychiatry is the treatment, study and prevention of mental disorders.

Daytime insomnia impact varies by subtype

Insomnia’s daytime impact appears to be greatest among those patients who have trouble both initiating and maintaining sleep, those with poor mental health, and those with childhood onset of the disorder, findings from the Great British Sleep Survey suggest.

14 Jan 2013

Off-label drug ineffective in frontotemporal dementia

A randomized, controlled trial has dashed hopes that memantine therapy could benefit patients with frontotemporal dementia.

14 Jan 2013

White matter abnormalities may indicate genetic risk for bipolar disorder

White matter abnormalities in the right temporal lobe may be a marker of genetic risk for bipolar disorder, results from a US study suggest.

14 Jan 2013

Link between environmental tobacco smoke and dementia syndromes

Passive smoking, also known as 'second-hand' smoke or environmental tobacco smoke (ETS), is known to cause serious cardiovascular and respiratory diseases, including coronary heart disease and lung cancer.

10 Jan 2013

Oxaliplatin and bevacizumab disappoint for rectal cancer

The addition of bevacizumab and oxaliplatin to standard neoadjuvant chemoradiotherapy does not enhance clinical response rates in rectal cancer, show phase II study results.

9 Jan 2013

Cerebrospinal fluid IL-6 increased in schizophrenia

Cerebrospinal fluid levels of interleukin-6 are significantly increased in patients with schizophrenia and major depressive disorder, Japanese study results show.

9 Jan 2013

Study shows troubling racial disparities in completion of alcohol and drug abuse programs

Roughly half of all black and Hispanic patients who enter publicly funded alcohol treatment programs do not complete treatment, compared to 62 percent of white patients, according to a new study from a team of researchers including the Perelman School of Medicine at the University of Pennsylvania.

9 Jan 2013

Asthma linked to pulmonary embolism risk

Patients with asthma have an increased risk for pulmonary embolism, show Dutch findings.

8 Jan 2013

Psychologic treatment has long-term benefits for bipolar patients

Psychoeducation and cognitive behavioral therapy combined with pharmacologic treatment provides significant long-term benefits for patients with refractory bipolar disorder, researchers report.

8 Jan 2013

Cost-ineffective drug prescribing practices revealed

Around four in 10 physicians prescribe a brand-name drug due to a patient request, when a generic equivalent is available, find researchers.

8 Jan 2013

Contingency management benefits drug-dependent mental health patients

Contingency management significantly reduces stimulant drug use in dependent patients with serious mental illnesses, researchers report.

8 Jan 2013

Dementia diagnosis: an interview with Dr Andrew Blackwell, Chief Scientific Officer, Cambridge Cognition

Dementia is a huge public health problem, affecting about 800,000 people in the UK and 36 million people around the world.

8 Jan 2013

Penn study suggests dopamine treatments may play role in increasing impulsivity

While approximately one in five Parkinson's disease patients experience impulse control disorder symptoms, the disease itself does not increase the risk of gambling, shopping, or other impulsivity symptoms, according to research from the Perelman School of Medicine at the University of Pennsylvania.

8 Jan 2013

Newly discovered gene predicts HCV interferon response

Researchers have discovered a gene which interferes with the clearance of hepatitis C virus infection.

7 Jan 2013

Vaccine gives HIV patients a long-term boost

A functional cure for HIV-1 seems feasible after research shows that an immunotherapeutic vaccine demonstrated long-term efficacy at reducing viral load when administered to patients in the early stages of disease.

7 Jan 2013

Industry sponsored drug and device studies: an interview with Professor Lisa Bero

Our review included analyses of drug and device studies conducted in humans. The drugs or devices could be compared to placebo or sham treatments, or other effective treatments. The drugs and devices examined for this review are used for a wide variety of clinical conditions, including cardiovascular and psychiatric diseases.

7 Jan 2013